Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 11, 2021
Patent Application Number
16542381
Date Filed
August 16, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
